2010
DOI: 10.1590/s1677-54492010000300009
|View full text |Cite
|
Sign up to set email alerts
|

Estudos clínicos de não-inferioridade: fundamentos e controvérsias

Abstract: Estudos de não-inferioridade são modelos experimentais desenvolvidos com o objetivo de determinar se um novo tratamento ou procedimento não é menos eficaz que outro já estabelecido e considerado como controle. São de grande importância no estudo de tratamentos em que o uso de placebo é inviável. Requerem metodologia diferente dos estudos clássicos, chamados de estudos de superioridade, especialmente no planejamento e análise estatística. O presente artigo é uma revisão dos principais elementos diferenciais ent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
22
0
8

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(31 citation statements)
references
References 19 publications
0
22
0
8
Order By: Relevance
“…We believe that, although evidence-based medicine would require randomized controlled clinical studies, comparing conventional and alternative treatments, for example using non-inferiority screening 46 , we questioned whether study would be feasible, even at multi-institutional level, since the number of patients needed in each arm would be very high, associated with the lack of early cases eligible for the method. The ethical discussion in randomizing this group of patients is associated with this fact, offering for them a treatment with greater morbidity and similar oncological results, as already demonstrated in the literature and the results presented here.…”
Section: Lip and Oral Cavity Tumorsmentioning
confidence: 99%
“…We believe that, although evidence-based medicine would require randomized controlled clinical studies, comparing conventional and alternative treatments, for example using non-inferiority screening 46 , we questioned whether study would be feasible, even at multi-institutional level, since the number of patients needed in each arm would be very high, associated with the lack of early cases eligible for the method. The ethical discussion in randomizing this group of patients is associated with this fact, offering for them a treatment with greater morbidity and similar oncological results, as already demonstrated in the literature and the results presented here.…”
Section: Lip and Oral Cavity Tumorsmentioning
confidence: 99%
“…In addition, multivariate analyses, comparison of subgroups to different numerical proportions, or multiple longitudinal comparisons, also involve higher complexity in sample sizing calculation. All these items exceed the scope of this paper 1,5,[7][8][9][10] .…”
Section: Infinite Populationmentioning
confidence: 99%
“…comparative efficacy studies, which are performed to compare a new treatment with a traditional treatment in order to show that the new one is not inferior, but also not superior, to the existing treatment. 13 Use of statins in cases with a known history of cerebral, peripheral or vascular disease, in which the patient remains functionally independent for activities of daily living and the life expectancy is more than five years, was also discussed and included for discussion in the second phase of the study. In this second phase, a consensus was achieved with regard to the evidence showing that the long-term benefit of statins in cerebral or peripheral atherosclerotic artery disease is poorer than that for coronary artery disease.…”
Section: Discussionmentioning
confidence: 99%